Success Stories: A Nigerian Bioinformatics Scientist Fellow Wins NIW Confirmation in Less Than 3 Months, Thanks to Our Case Preparation Strategy at NAILG

 

Client’s Testimonial:

“Right from my first contact with NAILG, it was an easy and smooth communication channel. They helped me resolve my doubt on the application process. The excellent attention to detail is impressive. Thank You for walking with me through this journey from application to approval in a short amount of time.”


On May 24th, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Bioinformatics Scientist Fellow in the Field of Biomedical Sciences (Approval Notice).


General Field: Biomedical Sciences

Position at the Time of Case Filing: Bioinformatics Scientist Fellow

Country of Origin: Nigeria

State of Residence at the Time of Filing: Georgia

Approval Notice Date: May 24th, 2022

Processing Time: 2 months, 27 days


Case Summary:

Getting an NIW (National Interest Waiver) approval without a Request for Evidence or RFE is not always easy. It requires thorough case preparation which means collecting evidence to prove the applicant’s value for the United States. So when we got an NIW client from Nigeria working in biomedical science we made sure that her case was well-prepared before applying for the approval. We ensured success by including the following information in her petition:

  • Her proposed endeavor is to work on her research to develop novel bioinformatics approaches for discerning the assembly of complex genomes, characterizing microorganisms, and accurately detecting pathogens in clinical diagnoses. This would help to determine the evolution and mutation of microorganisms and enable their resistance to therapies. Thus her research is significant as it helps elucidate how bacteria develop resistance to treatments such as antibiotics.
  • Her proposed endeavor also has specific implications for the United States since her work is critical to the treatment of illnesses such as antibiotic-resistant tuberculosis and Leishmania through the development of improved antibiotics and diagnostic tests.
  • On the other hand, due to its clear national importance, her research has in fact been supported with funding from the Centers for Disease Control and Prevention(CDC)
  • Her research has resulted in 4 peer-reviewed journal articles (2 of them first-authored) which have been cited 24 times already.
  • And her 7 years of experience won her accolades and recommendations from 4 other experts, one of who correctly said:
“[The client] is a valued and versatile research scientist, who has used her expertise and skillset to produce works that are of great use to the field of biomedical science.”

Thus, her journey to NIW approval was made easy by our team’s excellent case preparation which got her the approval in less than 3 months. We thank her for choosing our firm to represent her and we wish her all the best for the future.